Log in to save to my catalogue

Plasma proteomic signature of the risk of developing mobility disability: A 9‐year follow‐up

Plasma proteomic signature of the risk of developing mobility disability: A 9‐year follow‐up

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7189986

Plasma proteomic signature of the risk of developing mobility disability: A 9‐year follow‐up

About this item

Full title

Plasma proteomic signature of the risk of developing mobility disability: A 9‐year follow‐up

Publisher

England: John Wiley & Sons, Inc

Journal title

Aging cell, 2020-04, Vol.19 (4), p.e13132-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Introduction
Mobility disability is a powerful indicator of poor health in older adults. The biological and pathophysiological mechanism underlying the development of mobility disability remains unknown. This study conducted a data‐driven discovery phase investigation to identify plasma proteins that predict the incidence of mobility disability...

Alternative Titles

Full title

Plasma proteomic signature of the risk of developing mobility disability: A 9‐year follow‐up

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7189986

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7189986

Other Identifiers

ISSN

1474-9718

E-ISSN

1474-9726

DOI

10.1111/acel.13132

How to access this item